Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses
ABSTRACT Introduction and objectives: Infective endocarditis (IE) is a rare but serious complication in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). The spread of this technique to lower risk patients means that this complication may increase. The ob...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2025-05-01
|
| Series: | REC: Interventional Cardiology (English Ed.) |
| Subjects: | |
| Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=2639 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850134963145408512 |
|---|---|
| author | Lucas Barreiro Álvaro Roldán Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain Nerea Aguayo Cristina Urbano Manuel Crespín José López Rafael González Juan Carlos Castillo Dolores Mesa Martín Ruiz Jorge Perea Ignacio Gallo Javier Suárez de Lezo Soledad Ojeda Manuel Pan Manuel Anguita |
| author_facet | Lucas Barreiro Álvaro Roldán Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain Nerea Aguayo Cristina Urbano Manuel Crespín José López Rafael González Juan Carlos Castillo Dolores Mesa Martín Ruiz Jorge Perea Ignacio Gallo Javier Suárez de Lezo Soledad Ojeda Manuel Pan Manuel Anguita |
| author_sort | Lucas Barreiro |
| collection | DOAJ |
| description | ABSTRACT Introduction and objectives: Infective endocarditis (IE) is a rare but serious complication in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). The spread of this technique to lower risk patients means that this complication may increase. The objective of this study was to analyze the incidence and mortality of IE in TAVI patients vs patients undergoing surgical aortic valve replacement (SAVR). Methods: We conducted an observational, single-center, retrospective cohort study that included all cases of IE diagnosed consecutively in a Spanish reference center from 2008 through 2022 in patients with TAVI vs SAVR. Results: The study included a total of 10 cases of IE in 778 patients treated with TAVI, with an incidence rate of 0.09/100 patients/year vs an incidence rate of 0.12/100 patients/year in surgical bioprostheses with 24 cases in 1457 patients (P = .64) (median follow-up of 49 months (p25-p75: 29-108). Clinical features were very similar, with 50% of TAVI patients having cardiac complications vs 33% of SAVR patients (P = .33). Although 40% of the patients from the TAVI group had a surgical indication for IE and 50% for SAVR, P = .49), only half of them underwent surgery in both groups (20% TAVI vs 25% SAVR; P = .93). No differences were reported in the 1-year mortality rate (30% TAVI vs 29% SAVR; P = .56). Conclusions: The incidence rate of IE in this long series of TAVI patients was low and despite the worse clinical profile of TAVI patients, no significant mortality differences were found compared with the group of patients with surgical bioprosthesis. |
| format | Article |
| id | doaj-art-cb248f708f6c4f92bdaa17c479d7db6b |
| institution | OA Journals |
| issn | 2604-7322 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Permanyer |
| record_format | Article |
| series | REC: Interventional Cardiology (English Ed.) |
| spelling | doaj-art-cb248f708f6c4f92bdaa17c479d7db6b2025-08-20T02:31:34ZengPermanyerREC: Interventional Cardiology (English Ed.)2604-73222025-05-0172758110.24875/RECICE.M24000489Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprosthesesLucas Barreiro0Álvaro Roldán Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, SpainNerea Aguayo1Cristina Urbano2Manuel Crespín3José López4Rafael González5Juan Carlos Castillo6Dolores Mesa7Martín Ruiz8Jorge Perea9Ignacio Gallo10Javier Suárez de Lezo11Soledad Ojeda12Manuel Pan13Manuel Anguita14Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Facultad de Medicina y Enfermería, Universidad de Córdoba, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Facultad de Medicina y Enfermería, Universidad de Córdoba, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Facultad de Medicina y Enfermería, Universidad de Córdoba, Córdoba, SpainServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), SpainABSTRACT Introduction and objectives: Infective endocarditis (IE) is a rare but serious complication in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). The spread of this technique to lower risk patients means that this complication may increase. The objective of this study was to analyze the incidence and mortality of IE in TAVI patients vs patients undergoing surgical aortic valve replacement (SAVR). Methods: We conducted an observational, single-center, retrospective cohort study that included all cases of IE diagnosed consecutively in a Spanish reference center from 2008 through 2022 in patients with TAVI vs SAVR. Results: The study included a total of 10 cases of IE in 778 patients treated with TAVI, with an incidence rate of 0.09/100 patients/year vs an incidence rate of 0.12/100 patients/year in surgical bioprostheses with 24 cases in 1457 patients (P = .64) (median follow-up of 49 months (p25-p75: 29-108). Clinical features were very similar, with 50% of TAVI patients having cardiac complications vs 33% of SAVR patients (P = .33). Although 40% of the patients from the TAVI group had a surgical indication for IE and 50% for SAVR, P = .49), only half of them underwent surgery in both groups (20% TAVI vs 25% SAVR; P = .93). No differences were reported in the 1-year mortality rate (30% TAVI vs 29% SAVR; P = .56). Conclusions: The incidence rate of IE in this long series of TAVI patients was low and despite the worse clinical profile of TAVI patients, no significant mortality differences were found compared with the group of patients with surgical bioprosthesis.https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=2639Infectious endocarditis Aortic stenosis Surgical aortic valve replacement Transcatheter aortic valve implantation |
| spellingShingle | Lucas Barreiro Álvaro Roldán Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain Nerea Aguayo Cristina Urbano Manuel Crespín José López Rafael González Juan Carlos Castillo Dolores Mesa Martín Ruiz Jorge Perea Ignacio Gallo Javier Suárez de Lezo Soledad Ojeda Manuel Pan Manuel Anguita Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses REC: Interventional Cardiology (English Ed.) Infectious endocarditis Aortic stenosis Surgical aortic valve replacement Transcatheter aortic valve implantation |
| title | Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses |
| title_full | Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses |
| title_fullStr | Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses |
| title_full_unstemmed | Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses |
| title_short | Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses |
| title_sort | infectious endocarditis on percutaneous aortic valve prosthesis comparison with surgical bioprostheses |
| topic | Infectious endocarditis Aortic stenosis Surgical aortic valve replacement Transcatheter aortic valve implantation |
| url | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=2639 |
| work_keys_str_mv | AT lucasbarreiro infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT alvaroroldanserviciodecardiologiahospitaluniversitarioreinasofiacordobaspain infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT nereaaguayo infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT cristinaurbano infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT manuelcrespin infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT joselopez infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT rafaelgonzalez infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT juancarloscastillo infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT doloresmesa infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT martinruiz infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT jorgeperea infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT ignaciogallo infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT javiersuarezdelezo infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT soledadojeda infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT manuelpan infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses AT manuelanguita infectiousendocarditisonpercutaneousaorticvalveprosthesiscomparisonwithsurgicalbioprostheses |